content

Australia Injects $5.5 M To Heal Low Survival Breast Cancers

In a development that gives a big sigh of relief to the breast cancer fraternity, funding of a couple of clinical trials which could...

Synairgen announces global strategic partnership with Ashfield Engage

Synairgen plc, the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment...

ICRA Sees Growth In Indian Pharma Industry By 9-11% In FY22

Driven by the push from emerging as well as domestic markets in the upcoming quarters, the Indian Pharma industry in the Financial Year-22 is...

Ashfield Engage, Alliance Medical and NHS partner to identify early-stage lung cancer

Ashfield Engage, part of UDG Healthcare, has partnered with Alliance Medical to forge a new collaboration delivering the Targeted Lung Health Check (TLHC) programme...

FDA Nod Given To Wuxi STA Shanghai Facility After Inspection

WuXi AppTecโ€™s WuXi STA has said that its facility at Waigaoqiao near Shanghai has cleared its first FDA drug product pre-approval inspection. Notably, the...

ChargePoint Technology Acquires Terracon Corporation

ChargePoint Technology, the powder transfer specialist, has today announced the acquisition of Terracon Corporation a leader in the design, development, and manufacture of single-use...

In-Vitro Biology Capabilities Expanded By Piramal Pharma

Piramal Pharma Solutions has confirmed that it has put in a multi-million dollar investment to create a top-notch screening facility that will elevate the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read